The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPressure Tech Regulatory News (PRES)

Share Price Information for Pressure Tech (PRES)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 37.50
Bid: 36.00
Ask: 39.00
Change: 0.00 (0.00%)
Spread: 3.00 (8.333%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 37.50
PRES Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of the sale of Greenlane Biogas

4 Jun 2019 07:00

RNS Number : 0071B
Pressure Technologies PLC
04 June 2019
 

 

 

4 June 2019

 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE EU MARKET ABUSE REGULATION (596/2014). UPON THE PUBLICATION OF THE ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

Pressure Technologies plc

("Pressure Technologies" or "the Group")

 

Completion of the sale of Greenlane Biogas

Pressure Technologies (AIM: PRES), the specialist engineering group, is pleased to announce that further to its update on 28 May 2019 it has now completed the sale of its wholly-owned subsidiary, PT Biogas Holdings Limited ("Greenlane"), which is the holding company for the Group's Alternative Energy Division, to Creation Capital Corp (TSX-V: CRN.P) ("Creation Capital"), a capital pool company listed on the TSX Venture Exchange ("TSX-V"), for an aggregate price of £11.1 million (the "Sale").

Commenting on the Sale, Joanna Allen, Chief Financial Officer of Pressure Technologies, said: "The completion of this sale concludes the Board's process to realise the potential of the Greenlane Biogas business in the expanding market for renewable natural gas. I would like to thank the Greenlane team for their hard work and wish them and the new leadership team all the best for their future as Greenlane Renewables Inc. We will remain a supportive shareholder and anticipate retaining our holding for the medium term."

Summary of the Sale

The aggregate purchase price of £11.1 million is before adjustments for working capital and debtlike items based on a lock box balance sheet as at 2 February 2019. Under a lock box pricing mechanism, the purchase price is adjusted based on an historical balance sheet and there are no further post-closing adjustments for cash, debt and working capital. The lock box adjustments have reduced the consideration to £10.1 million.

Following the conclusion of the private placement, the final consideration for the Sale is therefore comprised:

· £2.0 million cash;

· £2.0 million of Consideration Securities in Greenlane Renewables Inc, representing a 21% holding after satisfaction of certain fees and completion incentives; and

· £6.1 million by way of a promissory note (the "Promissory Note"). The Promissory Note will (i) be denominated 50 per cent. in pounds sterling and 50 percent in Canadian dollars; (ii) mature 48 months from Completion; (iii) bear interest at the rate of 7% per annum and (iv) be secured by a pledge of all of the issued and outstanding Greenlane Ordinary Shares and all of the assets of Greenlane.

A Pressure Technologies nominee will be appointed as an outside observer to all Greenlane Renewables Inc. board meetings and activities until such time as the Promissory Note, together with all accrued and unpaid interest, is paid in full and retired.

Further details will be available in due course under Creation Capital's SEDAR profile and can be accessed via this link. Link to SEDAR.

Benefits of the Sale

The cash to be received by the Group on Completion will be used to pay down the Group's debt and the strengthened balance sheet will enable the Group to focus investment on its core specialist engineering businesses. As at 30 September 2018, the Group's net debt was £6.7 million.

 

For further information, please contact:

 

Pressure Technologies plc

Chris Walters, Chief Executive

Joanna Allen, Chief Financial Officer

 

Tel: 0114 257 3616

www.pressuretechnologies.com

Cantor Fitzgerald Europe (Nominated Adviser and Broker)

Tel: 020 7894 7000

Philip Davies / Will Goode

 

Belvedere Communications

Keeley Clarke (kclarke@belvederepr.com)

Cat Valentine (cvalentine@belvederepr.com)

 

 

Tel: 07967 816 525

Tel: 07715 769 078

 

COMPANY DESCRIPTION

 

Company description - www.pressuretechnologies.com  

With its head office in Sheffield, Pressure Technologies was founded on its leading market position as a designer and manufacturer of high-pressure components and systems serving the global energy, defence and industrial gases markets.

Precision Machined Components - www.pt-pmc.com

● Al-Met, Mid Glamorgan, acquired in 2010 www.almet.co.uk 

● Roota Engineering, Rotherham, acquired in March 2014 www.roota.co.uk 

● Quadscot, Glasgow, acquired in October 2014 www.quadscot.co.uk 

● Martract Limited, Barton-on-Humber, acquired in December 2016 www.martract.co.uk 

 

Cylinders

Chesterfield Special Cylinders, Sheffield, IPO cornerstone in 2007 and includes, CSC Deutschland Gmbh, which is based in Dorsten, Germany and Chesterfield Special Cylinders Inc. which is based in Houston, USA www.chesterfieldcylinders.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DISCKNDKBBKBOAK
Date   Source Headline
23rd Nov 20169:49 amRNSChange of Registrar
11th Oct 20162:09 pmRNSGrant of Share Options
10th Oct 20161:40 pmRNSNotice to Shareholders in accordance with FRS 101
30th Aug 20167:00 amRNSUpdate on Recent Trading
3rd Aug 20164:27 pmRNSGrant of Share Options
14th Jun 20167:00 amRNSHalf-year Report
27th Apr 20167:00 amRNSUpdate on Recent Trading
2nd Mar 20162:05 pmRNSExercise of Options
17th Feb 20161:14 pmRNSResult of AGM
17th Feb 20167:00 amRNSAGM Statement
11th Feb 20167:00 amRNSUpdate on investigation into fatality
26th Jan 20161:45 pmRNSCapital Markets Day
22nd Jan 20163:42 pmRNSIssue of Equity
15th Jan 201610:50 amRNSIssue of Equity
8th Jan 20163:05 pmRNSPublication of Annual Report and Notice of AGM
23rd Dec 20157:00 amRNSExercise of Options
23rd Dec 20157:00 amRNSGrant of Share Options
15th Dec 20157:00 amRNSFinal Results
17th Nov 20157:00 amRNSExercise of Options
10th Nov 20157:00 amRNSFull Year Trading Update
5th Oct 201510:22 amRNSHolding(s) in Company
5th Oct 20157:00 amRNSDirector Shareholding
1st Oct 20155:20 pmRNSExercise of Options
29th Sep 20152:30 pmRNSExercise of Options
11th Sep 20157:00 amRNSEXERCISE OF OPTIONS
2nd Sep 20157:00 amRNSIssue of Equity
27th Aug 20157:01 amRNSDirectorate Change
30th Jul 20151:18 pmRNSGrant of Share Options
25th Jun 20154:00 pmRNSGrant of Share Options
16th Jun 20157:01 amRNSDirectorate Change
16th Jun 20157:00 amRNSHalf Yearly Report
15th Jun 20157:00 amRNSChange of Adviser
4th Jun 20157:00 amRNSUpdate on Trading and Notice of Interim Results
27th May 20159:40 amRNSHolding(s) in Company
8th Apr 20153:25 pmRNSHolding(s) in Company
7th Apr 201511:13 amRNSHolding(s) in Company
2nd Apr 20153:47 pmRNSHolding(s) in Company
6th Mar 20153:48 pmRNSHolding(s) in Company
12th Feb 20154:20 pmRNSResult of AGM
5th Feb 20157:00 amRNSUpdate on Trading and Prospects
30th Jan 20153:14 pmRNSTotal Voting Rights
22nd Jan 20159:00 amRNSHolding(s) in Company
19th Jan 20157:00 amRNSProperty Acquisition
23rd Dec 20143:50 pmRNSIssue of Equity
19th Dec 20143:46 pmRNSPublication of Annual Accounts
19th Dec 20143:39 pmRNSHolding(s) in Company
15th Dec 20147:30 amRNSGrant of Share Options
9th Dec 20147:00 amRNSFinal Results
28th Nov 20147:00 amRNSTotal Voting Rights
27th Nov 201411:21 amRNSChange of Registered Office

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.